Physician profile
John G Moore
NPI 1629065628
$2,585.40
in general payments reported to CMS, 2019-2025
33 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $265 · 2021: $818 · 2022: $383 · 2023: $368 · 2024: $81.59 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $965.82 | 2019-2023 | |
| Astellas Pharma US INC | $251.77 | 2023-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $203.06 | 2021-2022 | |
| Covidien Lp | $143.69 | 2019 | |
| Agile Therapeutics, INC. | $116.31 | 2021-2023 | Twirla |
| Pfizer INC. | $82.26 | 2020-2022 | |
| Baxter Healthcare | $78.82 | 2019-2022 | |
| Revvity, INC. | $71.20 | 2023 | |
| Organon LLC | $61.96 | 2021-2024 | Nexplanon |
| Shield Therapeutics INC | $60.32 | 2023-2024 | Accrufer |
| Evofem Biosciences, INC. | $58.05 | 2021-2022 | |
| Avion Pharmaceuticals | $54.14 | 2019-2021 | |
| Ethicon US, LLC | $53.65 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $37.58 | 2022-2025 | |
| Therapeuticsmd, INC. | $34.53 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $26.59 | 2019 | |
| Allergan, INC. | $25.70 | 2019 | |
| Mallinckrodt Enterprises LLC | $22.64 | 2019 | |
| Scynexis, INC. | $21.19 | 2022 | |
| Duchesnay USA Incorporated | $20.93 | 2019 | |
| Medtronic, INC. | $19.96 | 2024 | Interstim |
| Mylan Pharmaceuticals INC. | $19.56 | 2021 | |
| Optumhealth Care Solutions, LLC | $18.13 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Aspira Women'S Health INC | $16.57 | 2021 | |
| Axonics, INC. | $16.26 | 2021 | |
| Coopersurgical, INC. | $14.54 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.77 | 2019 | |
| Hologic Sales and Service, LLC | $13.57 | 2020 | |
| Exeltis, USA INC. | $13.37 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.83 | 2019 | |
| Dysis Medical, INC. | $12.22 | 2021 | |
| Millicent US INC | $11.49 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.